SCHEMBL312896

SCHEMBL312896

CC(C)(C)C(=O)Nc1ncc2ccnc-2[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HPGD P15428 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
KDM4E B2RXH2 3/20 0.39
MAPT P10636 2/20 0.39
TP53 P04637 2/20 0.39
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
LMNA P02545 3/20 0.37
PAX8 Q06710 1/20 0.37
KLF5 Q13887 1/20 0.37
TOP2A P11388 1/20 0.37
PKM P14618 1/20 0.36
POLB P06746 1/20 0.36
NFKB1 P19838 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30083304 0.81 PIN1 (0.37) ALDH1A1KDM4E
SCHEMBL7878824 0.74 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL1335315 0.74 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL9891523 0.69 POLB (0.50) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL12155313 0.68 MAPT (0.44) SMN1; SMN2ALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL855501 0.66 KDR (0.47) SMN1; SMN2ALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL13762360 0.66 PTGES (0.52) SMN1; SMN2ALDH1A1HPGDL3MBTL1MAPT
SCHEMBL8816338 0.66 PIN1 (0.43) SMN1; SMN2ALDH1A1L3MBTL1KDM4EMAPT
SCHEMBL15380931 0.66 MEN1 (0.42) MAPTNPC1RAB9APOLB
SCHEMBL12155318 0.65 ALDH1A1 (0.47) SMN1; SMN2ALDH1A1CYP1A2HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093229-B2 Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitors CONFORMA THERAPEUTICS CORPORATION (US) 2012-01-10 US disclosed
US-20090318387-A1 ALKYNYL PYRROLO[2,3-d]PYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS CONFORMA THERAPEUTICS CORPORATION 2009-12-24 US disclosed
US-7544672-B2 Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitors CONFORMA THERAPEUTICS CORPORATION (US) 2009-06-09 US disclosed
CN-101180297-A Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors CONFORMA THERAPEUTICS CORP (US) 2008-05-14 CN disclosed
EP-1869027-A2 ALKYNYL PYRROLOPYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS Conforma Therapeutics Corporation (US) 2007-12-26 EP disclosed
US-20060223797-A1 ALKYNYL PYRROLOPYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS CONFORMA THERAPEUTICS CORPORATION 2006-10-05 US disclosed
WO-2006105372-A2 ALKYNYL PYRROLOPYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS CONFORMA THERAPEUTICS CORPORATION (US) 2006-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318387-A1 ALKYNYL PYRROLO[2,3-d]PYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS HSP90AB2P, HSP90AB1, HSP90AA1 SMN1; SMN2 3569/4885ALDH1A1 991/4885CYP1A2 3893/4885
US-20060223797-A1 ALKYNYL PYRROLOPYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS HSP90AB2P, HSP90AB1, HSP90AA1 SMN1; SMN2 3457/4885ALDH1A1 978/4885CYP1A2 3657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.